Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03709433 · ClinicalTrials.gov registry record · NA
Open Trial of an ACT Skills Group and Mobile App for Worry
A NA study, sponsored by Utah State University.
- Completed
- Registry status
- NA
- Development phase
- 21
- Enrollment target
NCT03709433: Completed NA study, sponsored by Utah State University.
NCT03709433 is a NA study that has completed, run by Utah State University. The registered enrollment target is 21 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03709433, a NA study, has completed, sponsored by Utah State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 21 participants
- Enrollment target
Study Summary
This study is an open trial of acceptance and commitment therapy (ACT) groups combined with a mobile app for the treatment of Generalized Anxiety Disorder (GAD). The goal of this study is to evaluate if ACT groups and a mobile app are efficacious and acceptable in the treatment of GAD. Study hypotheses are: 1. Group ACT will lead to improvement in worry, anxiety, comorbid depression, functioning, and well-being. 2. Group ACT will also lead to improvement in theoretically relevant processes, namely psychological inflexibility, anxiety-related fusion, mindfulness, and progress towards values. 3. Combining a mobile app with group ACT will be credible, acceptable, and satisfactory to participants.
Primary Outcome
The PSWQ is a 16-item self-report measure of problematic worry. The PSWQ has validity and reliability in clinical samples.
Interventions
- BEHAVIORAL ACT groups and mobile app
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2018-09-17 |
| Est. Completion | 2020-04-15 |
| Phase | NA |
What the finished NCT03709433 record still lists
NCT03709433 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 21 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which ACT groups and mobile app is the first listed.
NCT03709433 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03709433 about?
NCT03709433 is a clinical study titled "Open Trial of an ACT Skills Group and Mobile App for Worry". This study is an open trial of acceptance and commitment therapy (ACT) groups combined with a mobile app for the treatment of Generalized Anxiety Disorder (GAD). The goal of this study is to evaluate if ACT groups and a mobile app are efficacious and acceptable in the treatment of GAD. Study hypoth...
What is the current status of trial NCT03709433?
This trial is currently completed. It is a NA study. The enrollment target is 21 participants. The study started on 2018-09-17. Estimated completion is 2020-04-15.
What interventions are being tested in trial NCT03709433?
The interventions under investigation include: ACT groups and mobile app (BEHAVIORAL).
Who is sponsoring clinical trial NCT03709433?
This trial is sponsored by Utah State University, which has 27 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03709433's enrollment target sits among peer trials
21 1762nd of 2000 higher than 233 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02447874 · 21 participants · Phase 1
Arginine Therapy for the Treatment of Pain in Children With Sickle Cell Disease
- NCT03826992 · 21 participants · Phase 1
Venetoclax Combined With Vyxeos (CPX-351) for Participants With Relapsed or Refractory Acute Leukemia
- NCT04107077 · 21 participants · Phase 2
Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer
- NCT04158635 · 21 participants · Phase 1
Gemcitabine, Nab-Paclitaxel, and Bosentan for the Treatment of Unresectable Pancreatic Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI